top of page
DNA Double Helix

Multi-Cancer Early Detection (MCED)

What is MCED? 

Multi-Cancer Early Detection Test (MCED) is a simple blood test that can detect up to 112 types of cancer. Unlike the traditional cancer tests, our MCED test analyzes circulating biomarkers in the blood to detect subtle signals associated with over 50+ common cancers. This includes hard-to-screen cancers with no routine tests available, giving you and your healthcare provider unprecedented insight into your cancer risk long before it becomes symptomatic.

In partnership with AGTC Genomics, all tests are conducted in AGTC Genomics lab which is a
CAP accredited lab and also certified by other Accreditations including ISO 17025 and ISO 15189. The test has been awarded the MySTI certificate by MOSTI Malaysia.

AGTC-Logo.png
Copy of Untitled Design_edited.png
Untitled design (17).png

Comprehensive

Our Comprehensive Package covers 112 Cancer Tests over 20 Categories and provides the best insight into any cancer.

woman-symbol-pink-icon.webp

Women

The Women's Package covers 37 tests over 7 categories and is suitable for woman to look into targeted catagories of cancer.

male-symbol-blue-icon.webp

Men

The Men's Package covers 15 tests over 5 categories which looks into the most common cancer found in men.

Outdoors Meeting

For more information on the MCED Test,

please contact our Business Development Team at: 

sales@pathlabs.com.sg

bottom of page